Oragenics Inc
Biotechnology
Healthcare
OGEN
7.30 K shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
1.32
52 week high
4.93
high
1.44
52 week low
0.00
low
1.32
growth
-68.46 %
previous Close
1.34
P/E ratio
-0
market cap
963 K
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-2.27 M
-2.48 %
eps
-3.10 %
15.07 %
eps surprise
0.00 %
net profit margin
-227203500.00 %
0.00 %
operating incoming
-1.71 M
15.39 %
net change in cash
-1.45 M
-156.62 %
cash on hand
1.97 M
-42.31 %
cost of revenue
0.00 %
top top